Together these results indicate that CXCL8 could be of predictive value for the severity and mortality of ARDS and more importantly suggests that CXCL8 inhibitors may decrease the mortality rate in these patients. The gene discussed is CXCL8; the disease is acute respiratory distress syndrome.